Literature DB >> 17024327

Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.

R Franco1, C Lluis, E I Canela, J Mallol, L Agnati, V Casadó, F Ciruela, S Ferré, K Fuxe.   

Abstract

The molecular basis for the known intramembrane receptor-receptor interactions among heptahelical receptors (G protein coupled receptors, GPCR) was postulated to be heteromerization based on receptor subtype specific interactions between different types of homomers of GPCR. Adenosine and dopamine receptors in the basal ganglia have been fundamental to demonstrate the existence of receptor heteromers and the functional consequences of such molecular interactions. The heterodimer is only one type of heteromeric complex and the evidence is equally compatible with the existence of higher order heteromeric complexes, where also adapter proteins such as homer proteins and scaffolding proteins can exist, assisting in the process of linking the GPCR and ion channel receptors together in a receptor mosaic that may have special integrative value and may constitute the molecular basis for learning and memory. Heteromerization of D(2) dopamine and A(2A) adenosine receptors is reviewed by Fuxe in another article in this special issue. Here, heteromerization between D(1) dopamine and A(1) adenosine receptors is reviewed. Heteromers formed by dopamine D(1) and D(2) receptors and by adenosine A(1) and A(2A) receptors also occur in striatal cells and open new perspectives to understand why two receptors with apparently opposite effects are expressed in the same neuron and in the nerve terminals. The role of accessory proteins also capable of interacting with receptor-receptor heteromers in regulating the traffic and the molecular physiology of these receptors is also discussed. Overall, the knowledge of the reason why such complex networks of receptor-receptor and receptor-protein interactions occur in striatal cells is crucial to develop new strategies to combat neurological and neuropsychiatric diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024327     DOI: 10.1007/s00702-006-0566-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  72 in total

Review 1.  Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.

Authors:  K Fuxe; L F Agnati; K Jacobsen; J Hillion; M Canals; M Torvinen; B Tinner-Staines; W Staines; D Rosin; A Terasmaa; P Popoli; G Leo; V Vergoni; C Lluis; F Ciruela; R Franco; S Ferré
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

2.  Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes.

Authors:  C Saura; F Ciruela; V Casadó; E I Canela; J Mallol; C Lluis; R Franco
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

Review 3.  Cell surface adenosine deaminase: much more than an ectoenzyme.

Authors:  R Franco; V Casadó; F Ciruela; C Saura; J Mallol; E I Canela; C Lluis
Journal:  Prog Neurobiol       Date:  1997-07       Impact factor: 11.685

4.  Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition.

Authors:  G Y Ng; S R George; R L Zastawny; M Caron; M Bouvier; M Dennis; B F O'Dowd
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

5.  Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells.

Authors:  G Y Ng; B F O'Dowd; M Caron; M Dennis; M R Brann; S R George
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

6.  Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization.

Authors:  C A Saura; J Mallol; E I Canela; C Lluis; R Franco
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

7.  (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl) glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices.

Authors:  A A Genazzani; M R L'Episcopo; G Casabona; H Shinozaki; F Nicoletti
Journal:  Brain Res       Date:  1994-10-03       Impact factor: 3.252

8.  Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.

Authors:  Samuel P Lee; Christopher H So; Asim J Rashid; George Varghese; Regina Cheng; A José Lança; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

9.  Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons.

Authors:  M Torvinen; S Ginés; J Hillion; S Latini; M Canals; F Ciruela; F Bordoni; W Staines; F Pedata; L F Agnati; C Lluis; R Franco; S Ferré; K Fuxe
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

View more
  25 in total

Review 1.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

2.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

Review 3.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

4.  Adenosinergic regulation of binge-like ethanol drinking and associated locomotor effects in male C57BL/6J mice.

Authors:  Brandon M Fritz; Stephen L Boehm
Journal:  Pharmacol Biochem Behav       Date:  2015-05-29       Impact factor: 3.533

Review 5.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

6.  Design, synthesis and biological evaluation of bivalent ligands against A(1)-D(1) receptor heteromers.

Authors:  Jian Shen; Lei Zhang; Wan-ling Song; Tao Meng; Xin Wang; Lin Chen; Lin-yin Feng; Ye-chun Xu; Jing-kang Shen
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

7.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

8.  Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.

Authors:  Hai-Ying Shen; Philipp Singer; Nikki Lytle; Catherine J Wei; Jing-Quan Lan; Rebecca L Williams-Karnesky; Jiang-Fan Chen; Benjamin K Yee; Detlev Boison
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

Review 9.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

10.  The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake.

Authors:  Carolyn E Pritchett; Alicia L Pardee; Sophia R McGuirk; Matthew J Will
Journal:  Brain Res       Date:  2009-10-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.